These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 19340447
1. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma. Zvrko E, Mikic A, Vuckovic L. Eur Arch Otorhinolaryngol; 2009 Dec; 266(12):1971-6. PubMed ID: 19340447 [Abstract] [Full Text] [Related]
2. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma. Zvrko E, Mikic A, Vuckovic L. Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039 [Abstract] [Full Text] [Related]
3. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma. Zvrko E, Mikic A, Vuckovic L, Djukic V, Knezevic M. Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216 [Abstract] [Full Text] [Related]
4. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q, Zhang B, Peng P. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [Abstract] [Full Text] [Related]
5. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma. Marioni G, Staffieri A, Manzato E, Ralli G, Lionello M, Giacomelli L, Prosenikliev V, Marchese-Ragona R, Busnardo A, Bolzetta F, Blandamura S. Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405 [Abstract] [Full Text] [Related]
6. Expression of CD105 but not of E-cadherin is associated with malignancy recurrence and disease-free interval in laryngeal cancer in men. Zvrko E, Vuckovic L. Folia Histochem Cytobiol; 2023 Feb; 61(3):183-192. PubMed ID: 37787034 [Abstract] [Full Text] [Related]
7. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression. Marioni G, Blandamura S, Loreggian L, Koussis H, Lionello M, Giacomelli L, Fasanaro E, Lovato A, Staffieri A. Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202 [Abstract] [Full Text] [Related]
8. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma. Marioni G, Ottaviano G, Giacomelli L, Staffieri C, Casarotti-Todeschini S, Bonandini E, Staffieri A, Blandamura S. Eur J Surg Oncol; 2006 Dec; 32(10):1149-53. PubMed ID: 16979866 [Abstract] [Full Text] [Related]
9. [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma]. Bodnar M, Szylberg Ł, Kaźmierczak W, Marszałek A. Przegl Lek; 2012 Dec; 69(10):726-30. PubMed ID: 23421020 [Abstract] [Full Text] [Related]
10. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma. Marioni G, Marino F, Giacomelli L, Staffieri C, Mariuzzi ML, Violino E, De Filippis C. Acta Otolaryngol; 2006 Jun; 126(6):633-9. PubMed ID: 16720449 [Abstract] [Full Text] [Related]
11. CD105- and CD31-assessed microvessel density in laryngeal carcinoma biopsies as a predictor of recurrence after exclusive primary surgery. Franz L, Alessandrini L, Saccardo T, Frigo AC, Marioni G. Ann Diagn Pathol; 2020 Oct; 48():151608. PubMed ID: 32890907 [Abstract] [Full Text] [Related]
12. [The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance]. Liu Y, Xue X, Wang F. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(3):100-3. PubMed ID: 18476626 [Abstract] [Full Text] [Related]
13. [Relationship between CD105 and angiogenesis and biological behaviors in squamous carcinoma of larynx]. Gu X, Xu Y, Wu H, Xu X. Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(3):125-8. PubMed ID: 16646406 [Abstract] [Full Text] [Related]
14. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma. Sakurai T, Okumura H, Matsumoto M, Uchikado Y, Owaki T, Kita Y, Setoyama T, Omoto I, Kijima Y, Ishigami S, Natsugoe S. Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351 [Abstract] [Full Text] [Related]
16. Microvessel density assessment in benign and malignant endometrial changes. Czekierdowski A, Czekierdowska S, Czuba B, Cnota W, Sodowski K, Kotarski J, Zwirska-Korczala K. J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753 [Abstract] [Full Text] [Related]
17. Endoglin (CD105) positive microvessel density and its relationship with lymph node metastasis in squamous cell carcinoma of the tongue. Eshghyar N, Mohammadi N, Rahrotaban S, Motahhary P, Vahedi Vaez SM. Arch Iran Med; 2011 Jul; 14(4):276-80. PubMed ID: 21726105 [Abstract] [Full Text] [Related]
18. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study. Rubatt JM, Darcy KM, Hutson A, Bean SM, Havrilesky LJ, Grace LA, Berchuck A, Secord AA. Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712 [Abstract] [Full Text] [Related]
19. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis. Martinović Ž, Kovač D, Martinović C. World J Surg Oncol; 2016 Apr 22; 14():122. PubMed ID: 27102733 [Abstract] [Full Text] [Related]
20. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S. Hum Pathol; 2006 Jul 22; 37(7):861-6. PubMed ID: 16784986 [Abstract] [Full Text] [Related] Page: [Next] [New Search]